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Abstract Cold chain management (CCM), a lynchpin of National 
Immunization Program (NIP) is to deliver the vaccines or other 
immunological products/ vaccines to right people, at right place, and in right 
time ineffective manner under the controlled conditions to ensure its potency. 
To comply it, CCM is required with standardized equipment’s and standard 
procedures to transport the immunological products to ensure the availability 
of high-quality vaccines and immunization-related materials to all levels 
of the program. It is vital to ensure accurate implementation of pertinent 
strategies focusing on vaccine storage; transportation, immunization, safety, 
management & monitoring. If the CCM is managed properly, the program 
costs can be reduced markedly without sacrificing the potency of product. 
Apart from that, high and unwanted vaccine wastage rates are due to poorly 
managed planning resulting into significant variation in operation program 
cost, improper management of waste with the negative impact on public 
health. 
The review enlightens on how vaccines are stored, transported and monitored 
to sustain immunological products/vaccines integrity throughout the way of 
their transportation emphasizing on the various equipment’s and logistic 
needs to cover the entire cold chain management rigorously till the reach 
of target population child/mother at the primary healthcare centers(PHCs).
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Immunization plays a significant role in survival of childhood across the globe. 
(Sachdeva, S. and Datta U. 2010) Major cause of morbidity and mortality 
among children as well as mother of developing countries are diseases like 
polio, measles, and hepatitis. These diseases are controlled and prevented 
by Vaccines under the immunization programs. (Hinman, A. 1999) Thus 
Immunization is one of the best and effect methods to control and prevent the 
childhood diseases. Immunization against a disease is achieved with the help 
of a potent vaccine to be vaccinated to the recipient in potent form. (Agrawal, 
D. K. 2005) India, itself contributes biggest Universal Immunization Program 
(UIP) across the nation where the most beneficiaries (almost 30.2 million 
pregnant women and 27 million infants) covered, the proportion of vaccines 
used is very high where the workers involved across 29 state boundaries and 
6 Union Territories. (Mishra, N., and Kumar, S. 2016) The entire cost for the 
program is more than Rs. 2000 crores which is used to against the vaccine 
preventable diseases in children. (Hanjeet, K. et. al. 1996) 
The program is mainly focused on six deadly Vaccine Preventable 
Diseases (VPD) i.e. Hepatitis B, Tetanus,  Tuberculosis,  Diphtheria, Pertussis, 
Polio and Measles. Apart from these diseases, Japanese Encephalitis (JE) is 
also included in Universal Immunization Program to protect the children in 
India. The channel of providing the Immunization services is well organized 
and vast. The health district hospitals, primary health centers are the integral 
part of infrastructure dealt with the immunization action plan along with the 
community health centers (CHC) and many sub-centers also. (Ministry of 
Health & Family Welfare, Government of India. 2003 and Baldiwala, Q. 2001)
To attain the successful immunization, an organized and well-planned 
cold-chain storage systems has developed consisting of State, District in 
associationsship of Government Medical Supply Depots (GMSD), PHC/ CHC 
vaccine storage points and Regional/Divisional centers. Vaccine stores and. 
The backbone of the immunization program is the cold chain to ensure the 
quality and right quantity reaches to the affected children, women, and other 
population. A predefined system of the logistic is essential for storing and 
transporting the vaccines. Primarily the vaccines reached to the main stores 
i.e. Government Medical Store Depots (GMSDs) and it is used to maintain 
the stock for maximum of 3 months. Karnal, Chennai, Mumbai and Kolkata 
are 4 Government Medical Store Depots in India.  The flow of vaccines is 
from vaccine stores of the states to through divisional to district and finally 
it reaches at last storage center of CHC or PHC. (Srinivasan R. 2005) These 







its potency throughout is expressed “cold chain.” Other names like vaccine 
supply chain, or the immunization supply chain are also used synonymously 
for cold chain.  This consists of a chain of storage and transport links, all of 
which are designed to retain the vaccines at controlled or ambient temperature 
to the reach of vaccine to target recipients. (Srinivasan R. 2005)  
Vaccine Adverse Event Reporting System (VAERS) presented data till 
Dec 2014 and found that the cases for hospitalization are 1244; cases of people 
reporting a disability are 416; 122 reported deaths; reported life-threatening 
cases are 388 . The following data presents the year and different reported 
cases of disability, hospitalization, deaths, or life-threatening illness presented 
on and the reason behind these are some spurious or deteriorated vaccines 
might be responsible. The deterioration is due to  improper storage, inadequate 
handling and unorganized/uncrontrolled transportation of  temperature 
sensitive products under bad cold chain. (Dr. Bob 2014)
Now one can understand how serious concerns are associated with the 
immunological products control, management, storage, and transportation to 
the target reach. So, cold chain management plays a remarkable role in entire 
immunization program and an error in coordination of vaccines leads to result 
even death of children, mother, patients, or other population after immunization. 
Thus, its challenging to preserve the vaccines under optimum temperatures 
for longer period during the transit. (Thakker, Y. et. al1992 and Bell, K. N. 
2001) Vaccines are wasted upto certain extent during the implementation of 
the immunization program and different states have different wastage rate 
which depends on the cold storage capacity and the available infrastructure. 
The vaccines are categorized on basis of their sensitivity whether it is freeze 
sensitive or heat sensitive. On basis of the sensitivity, the immunological 
products are stored, handled, and transported from one place to another till the 
immunization. (Nagdeve D and Bharti D. 2006) 
2. LITERATURE REVIEW
An alarming rise in the deaths of children after vaccination has put this issue 
under the scanner of the Union Health Ministry, Govt. of India and triggered off 
ripples of apprehension among the public. Times of India covered the a news 
of  128 children who died in 2010 and reason behind the death was adverse 
effects observed post immunization. The number of deaths has escalated over 
the past three years from 111 in 2008, 116 in 2009, 128 in 2010, 156 in 2014 
and 197 in 2016. According to media sources, the numbers only appear to be 
climbing upwards. Sources in the logistics industry and the medical fraternity 
are analyzing the cause of death and indicate that among other reasons, neglect 
of cold chain facilities could be a possible reason for such deaths. (Umit, K., 
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Milstien, J. 2014) Last year a shocking news published in Times of India 
dated 1 July 2016 stated about the National Immunization Program and Cold 
Chain Management stating that 25 per cent of the vaccines which contributes 
a huge proportion, go waste before the reach to doctors and followed by to 
the patients. Out of these, many vaccines may lose the potency or efficacy 
completely   due to poor control and logistics management for the cold chain.
It is a major challenge for the public health agencies and government 
mainly in the surrounding areas where supply chain logistic and infrastructure 
are in poor shape to control the cold chain management. (www.logistics 
week.com July 2015) To overcome the problem, Ministry of Health is now 
taking initiatives to put in action increasingly/additionally to manage the 
supply chain in a better way.  More than 27,000 cold chain points have been 
planned in intention to store and distribute of the vaccines. The world’s largest 
vaccination drive is Universal Immunization Program (UIP) which is planned 
to introduce a rigorous and real time electronic vaccine intelligence network 
(EVIN) to simplify the vaccine stock supervision and monitoring of cold chain 
temperature with the help of mobile technology. Majority of vaccines are heat 
sensitive and the potency of vaccines are maintained 2-8 °C. 
Dr Amin Kaba, a pediatrician at Saifee hospital, Mumbai, emphasized about 
the cold chain that most of the health care professionals are not having ample 
knowledge of cold chain facilities or even logistics and don’t understand how 
this could impact the health sector. Many health care professionals/doctor’s 
stores medicines in the door of the refrigerator in their clinics but if vaccines 
are stored in the door of refrigerators; it causes the vaccine to lose its potency. 
However, Dr. Kaba mentioned that it would not cause death —there are other 
factors too. The change in color of VVM reflects whether vaccine should be 
used or not if the quality of the vaccine has declined. Dr Usha Agboatwala, 
a Pediatrician at Mazagaon, Mumbai, says, “its critical to maintain the cold 
chain. If a vaccine is not properly preserved it becomes useless.”She also 
highlighted the state government’s preference for cheaper vaccines and the 
lack of a regulatory body to institute stringent quality control guidance to the 
stakeholders and it may be a possible reasons for such deaths. Other probable 
reasons for such deaths are poor immunity power of the children, improper 
administration of vaccines and acute malnourishment of young children who 
are unable to tolerate the vaccine dose. 
The largest number of deaths has been registered in Maharashtra. “Services 
in Maharashtra have been on the decline. In southern states, no quality check is 
there because situation is different and diligence is greater in the province.  Even 
Gujarat is better than Maharashtra in this regard and the deaths are occurring 







last mile. Generally, the inefficiencies exist at the last leg of a vaccine’s life 
cycle. (United Nations/AGECC 2010) The chances of errors in the last leg of 
distribution, storage and time lapse before vaccination at outreach points because 
this step is less monitored.  But the production and the first leg of distribution 
may still be well-controlled and monitored. Any lacunae in the protocol would 
also impact quality and efficacy of the vaccine. The pharmaceutical companies 
have taken various efforts to ensure the quality of the vaccines.  Hence it is vital 
to comply cold chain temperature as per the recommendation and avoid the 
cold chain breach. (United Nations/AGECC 2010)
The cold chain at the peripheral levels controlled and engaged by people 
i.e health workers to preserve the equipment and temperature. (Mallik s, et 
al. 2011 and Aggarwal, A, et. al. 1995) Adverse reactions and/or missed 
opportunities to vaccinate are the clinical outcomes resulting from cold chain 
break which denotes an inadequacy in “cold chain maintenance”. Goel et al 
reported that it is an unsatisfactory maintenance of the cold chain apparatus in 
their evaluation of cold chain system in Chandigarh. (Goel, N. K, et. al. 2004) 
Prior to reach the doctors and patients, about  25% of the vaccines may lose 
their potency  due to inadequate quality supply chain and logistics management 
system before the administration to the patients (Bachani, D. 1990 and Ortega, 
M. P., et. al. 2002)
Government and public health agencies is facing lot of temperature 
control related issues to address the immunization coverage, when supply 
chain logistics and set-ups are in poor shape. Thus a cold chain management 
is vital and crucial step to ensure quality or efficacy of vaccines or any other 
biologicals also. (Dr. Bob 2014)
The total wastage volume of vaccines is of 25% for all kind of vaccines 
with exception of BCG which wastes goes upto 50% as per Immunization 
Technical Support Unit (ITSU).  (Dr. Bob 2014)
In United States, severe vaccine adverse reactions have been reported so 
far to the Centers for Disease Control between 3,000 and 4,500. These are not 
mild reactions but severe reactions resulting hospitalization or in the intensive 
care units (ICUs) or death stated or cause a permanent disability as stated 
by by Dr. Bob Sears, a pediatrician (California), said on CNN (2 Feb 2015). 
Cold chain preservation is systematic and a continuous process to maintain 
temperatures between +2ºC to +8ºC to ensure their potency, efficacy while in 
transit, the storage process for vaccines from the manufacture point up to the 
beneficiary should be controlled and recorded in timely manner. (Srinivasan 
R. 2005) 
Environment conditions (such as temperature, heat, relative humidity, 
and light) affects the vaccines deadly if not controlled properly and it is the 
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utmost need to monitor the transferring, storing, handling, and holding areas 
throughout which the biologicals/vaccine passes.  To avoid any negligence 
during the cold management, the monitoring processes should enable the 
alarming of temperature excursion (control and monitoring tools) during the 
time of day and night. The data generated during the transit, should be archived 
much safely, data should be available on time and inspected out regularly.  (Le 
Tailec, D., et al. 2009) 
2. METHODOLOGY OF VACCINE BIOLOGICAL INTIGRITY 
The methodology explains different crucial steps to ensure the biological 
integrity of vaccines w.r.t. efficiency and potency. After compliance, of all 
requisite, one can ensure the potency of the vaccine till the child/mother 
immunization. 
2.1 Vaccine storage temperature and compliance
The temperature range between 36° F and 46°F (previously between 35° F and 
46° F) is being recommended by the Advisory Committee on Immunization 
Practices (ACIP). All the manufacturer inserts stated the Celsius temperature 
range (between 2°C and 8°C) which remain unchanged for vaccines. 
Throughout the proper vaccine storage and their handling plays a significant 
role to eradicate and prevent many common vaccine-preventable diseases. 
Many patients are being revaccinated because of storage and handling errors 
and significant financial loss due to wasted vaccine. Community losses 
confidence about to vaccinate their Children because the vaccines quality has 
been compromised during the handling.
The storage conditions of refrigerated vaccines lie between 2°C /36°F and 
8°C/46°F. Vaccines are stored in between -50° C/-58°F and -15°C/+5°F 
in the deep-freezer without any kind of excursions where the thermostat is 
an alternative tool to control and assure the appropriate frozen temperatures. 
(Aggarwal, K. et. al. 2002) Transportation of vaccine is based on the type of 
vaccines because vaccines are more prone towards the heat and freezing. 
Sensitivity to heat and freezing are crucial steps for immunological products 
management.  These vaccines are categorically placed as per the heat sensitivity 
as given in figure 1.1 
On basis of heat sensitivity, vaccines are generally grouped into six 
categories. (Samant, Y., et. al. 2007) The vaccines are categorized into six 
categories on basis of sensitivity to heat. The groups are A, B, C, D, E, F 
starting from most sensitive to heat (group-A) towards the less sensitive to 







freeze-dried vaccines only to unopened vials but the potency of the vaccines 
might be decreased rapidly after reconstitution. 
The light sensitive vaccines are liable to degrade when exposed to light 
and the freeze sensitive vaccines are liable to degrade when reaches to the 
freezing state. (Pande, R.P. 2003) Thus it’s always essential to protect the 
potency of the vaccines to provide an ambient temperature during the storage 
and transport.
There are the UIP guidelines for light and temperature which are to 
be followed during the cold chain management as given in the table 2 and 
its mandatory to control the temperature as described. Any temperature 
excursion (above and below) is enough to damage the potency of vaccines by 
understanding the above groups of the vaccines. (Samant, Y. 2007)
Figure. 1: Types of Vaccines based on heat sensitivity.


















Table 2. List of freeze and light sensitive vaccines.
VACCINES
Freeze sensitive Light sensitive
DTap-hepatitis B-Hib-IPV (hexavalent) Few vaaccines are  light sensitive 
and loss theis potency when they are 
exposed to it i.e. sunlight/artificial 
light. Light sensitive vaccines are heat 
sensitive also.
Cholera
Hepatitis B (Hep B)
Hib (Liquid) BCG
Influenza, Rotavirus (liquid & freeze 
dried)
Measles-mumps-rubella
Inactivated poliovirus (IPV) Measles-rubella
Human Papillomavirus (HPV) Measles
Pneumococal, Tetanus, DT, Td Rubella
Table 3: Temperature limitations of vaccines.






Heat and light sensitive  vaccines  
Measles vaccine Light and Heat 
sensitive
No damage under 
freezing
+2°C to +8 °COPV* vaccine Sensitive to heat
OPV* vaccine Relatively heat stable, 




Relatively heat stable Freezes at -0.5°C
(Should not be frozen)
+2°C to +8 °C
TT** vaccine Relatively heat stable Freezes at -3°C
(Should not be frozen)
DT*** vaccine Relatively heat stable Freezes at -3°C
(Should not be frozen)
DPT**** 
vaccine
Relatively heat stable Freezes at -3°C
(Should not be frozen)
*OPV :  Oral Polio Vaccine; TT**: Tetanus Toxoid,  DT*** : Diphteria and Pertusis,  DPT**** : 







The temperature excursions can be avoided by using 1. Excellent refrigeration 
units; 2. Excellent thermometers; 3. Rapid notification of issues before they 
become problems; 4.  Excellent staff & excellent guidance which is most 
important but most variables.
2.2. Cold chain Management (CCM)
The cold chain management (CCM)is defined as the surrounding controlled 
temperature used to maintain and distribute vaccine under optimal conditions 
to protect its quality throughout. Three components are the main basis of an 
effective and relieable cold chain and thee are:-
• An expertised and well trained professional/staff/worker.
• Equipments of  reliable features like well calibrated  or proper storage capacities.
• Precise and validated vaccine monitoring system
It is continuous process of control the storage and transporting the vaccines 
at the desired temperature series from manufacturing premise to the point of 
use. CCM is the need of hour and a vast cold chain infrastructure required to 
deliver potent, efficacious, and effective vaccine to last users like patients/
mothers/children/adolescent girls etc. from the manufacturer to the primary 
vaccine stores. (Levinson 2012 and Wirkas, T., et al. 2007) 
2.3. Levels of cold chain system
Different levels of CCM are a decentralized management system in which 
areas are categorized on Primary, Intermediate and Peripheral level. 
Figure 2: Cold Chain Flow Chart.
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Various kinds of equipments for transportation and storage of the vaccines 
under the cold temperature are used to fulfill the need of different level needs. 
These equipments assist to maintain the integrity of the vaccines providing the 
vaccine ambient temperature to sustain its potency and allow the immunization 
program in effective manner. (Matthias DM et al. 2007) These different levels 
are: 
2.4 Monitoring the cold chain
Many vaccines are very heat resistant and might be shipped without insulation 
from manufacturers to the end users at PSCs. But they might be deteriorated 
at or above the temperature of +48°C. To control and assess the excursions of 
the temperature a special device is required to monitor the transit and delivery 
temperatures. 
For each shipment, an individual indicator is included and the staff must 
know how temperatures are monitored and understand how to interpret 
temperature readings from the instrument to avoid damage of vaccines. 
(Burgess, M.A., and McIntyre P.B. 1999) It is true for cold chain equipment that 
any machinery performance will always be good if it is effectively monitored 
and controlled by personnel.  Cold chain system should be monitored regularly, 
to safeguard the vaccines. (Afsar A and Kartoglu U. 2006) 
The vaccine integrity like potency/efficacy and its overall effectiveness 
maintained and it should be kept in its safe temperature range to achieve the 
desired therapeutic results as suggested. One must understand the basics of 
monitoring the vaccines during the storage and transportation as given below:
Table 4. Levels of Vaccine reach.
Levels Management
Primary level National  At national level, the freezers, cold rooms, 
cold boxes freezer rooms, refrigerators, 




Province/District At district level cold boxes, cold/
freezer rooms, freezers, refrigerators and 
sometimes refrigerated trucks are used for 
bulk vaccine transportation.
Peripheral level health center/ 
health post
Generally, room refrigerators are used for 
health centers and Cold boxes, Gel Packs 









Vaccine impairment is the result of the inadequate handling of the immunological 
product during the handling, storage, shipment, or use. There are many ways 
to assess the biologicals/vaccines whether to use or not to use. One criteria is 
to evaluate the physical appearance of the vaccine but the physical appearance 
Figure 3: Cold chain maintenance flow chart as per WHO protocol.
Table 5: Recommended temperature ranges of Vaccines.




Hepatitis B and DTP All
+ 8°C + 2°CDT, TT Storage
Diluent Point of Use
Diluent Transport
Ambient + 2°CDiluent Storage
DT, TT Transport + 40°C + 2°C
OPV, Measles, Yellow 
fever, BCG* 
All + 8°C -20°C
*BCG : Bacillus Calmette-Guerin
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of many vaccines may remain unchanged even after it is damaged. Therefore, 
it is essential to know about the loss of potency due to either exposure to heat 
or cold to protect the vaccine from impairment.
2.4.2 Heat Damage
Vaccines are heat sensitive hence damaged by temperatures stored more than 
+8oC. It might be damaged exposed to heat in a short period like keeping 
vaccines in a closed container but exposed to the sun or a small amount of 
heat for a long period for example recurrent opening of lid of ILR during the 
exposure of heat.  The risk of contamination for reconstituted BCG, measles, 
and Japanese Encephalitis (JE) vaccines is high due to their high sensitivity 
towards the heat and light.  Because to these reasons, BCG uses time is very 
short and should be used within 4 hours of its reconstitution while JE vaccine 
should not be used after 2 hrs of reconstitution. (Jain, R., et. al. 2003) 
2.4.3 Heat Damage evaluation: The Vaccine Vial Monitor(VVM): 
 VVM is described as a label which is placed on a vial of vaccine to register 
cumulative heat exposure over the time and because VVM is composed of a 
heat-sensitive material which changes in its coloration on exposure of light/
heat. (Chudasama, R..K., et. al. 2009)  
The main factors which affects the coloration of inner square are 
temperature and time which causes the color changes from lighter to darken 
on inner square of the VVM gradually and irreversibly. It’s essential to ensure 
the status of the VVM, before opening a vial. But it does not mean that potency 
of the vaccines can be measured directly by VVM. VVM only gives evidence 
about the factors responsible for potency like heat exposure over a period. The 
exposure to freezing (responsible for degradation of freeze-sensitive vaccines) 
cannot be measure by the VVM.  (Jezek J. et al. 2009 and Schondorf, I., et. 
al. 2007) Therefore, the monitoring of the vaccine or immunological products 
handling is a crucial step in NIP where the VVM has a great role to assess the 
use or not to use the vaccines. 
2.4.4 Electronic Vaccine Intelligent Network (eVIN)
United Nations Development Program (UNDP) control the overall the 
immunization program and strengthen the Universal Immunization Programme 
(UIP) with the appropriate designing and implementing an Electronic Vaccine 
Intelligence Network (eVIN). The entire eVIN system works in association 
with the Ministry of Health and Family Welfare, Government of India.  The 
improved policy-making in procurement, vaccine delivery and planning for 







observed that it must be designed and implemented to achieve the targeted 
vaccine deliveries with the optimum temperature control and potency in all 
districts (371 districts of India).  
The eVIN system is enable to get the real time information on cold 
chain temperatures and vaccine stocks along with the flows of vaccine in 
all the districts of Madhya Pradesh, Rajasthan and Uttar Pradesh that count 
approximately 160. It’s capable enough to keep the record of more than 
10,500 vaccine stores and cold chain points in more than 12 states at one time. 
More than 2 million transactions of the vaccine data can be logged online at 
a time without any stuck-up of eVIN server. It has many advantages that it 
really strengthened entire immunization program of the state by arraying the 
managers who control the vaccine and cold chain in the districts to approximate 
the need of vaccines, to oversee the cold chain handlers across the district 
in coordination with cold chain technicians.  This eVIN is standardized and 
authorized by the Government of India at every cold chain point to facilitate 
the efficient vaccine record-keeping through providing distribution register 
Table 6: Representation of VVM check.
Square Mark (Yes/No) Description
√
The vaccine may be used till the inner square 
is lighter than the outer circle but check expiry 
date, it is over or not. If vaccine expiry is over, 
then color of the square doesn’t matter.
Vaccine can still be used if the inner square is 
still lighter than the outer circle with expiry date 
of vaccine has not passed. 
Discard Point: When the color of the inner 
square matches with outer circle and there is 
no difference in outer circle and square box 
coloration. Then avoid to use the vaccine.
 
Beyond the discard point:  this is a critical 
condition for vaccine and If the coloration of the 
inner square is darker than the outer circle, it is 
strongly recommended not using the vaccine. 
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and standard stock. It also supports to the UIP to guide and coordinating the 
vaccine and immunization research network (VIRN) and Scientific Advisory 
Group (SAG). (UNDP).
The efficiency of the eVIN is such a way that it has been selected as a “best 
practice” at the National Summit on Good, Replicable and Innovative Practices 
and recognized as one of the premier scalable models in health care system. 
It is also considered as one of the best digital innovation under the Ministry 
of Health and Family Welfare, Govt. of India at the India International Trade 
Fair 2016. It developed in such a way to ensure the precise monitoring of the 
temperature by installing nearly temperature loggers to record the excursions 
during the storage, handling and transit.
3. EQUIPMENTS/DEVICES USED TO CONTROL TEMPERATURE 
Various equipment are recommended for the storage of vaccines under the 
set temperature conditions around the year. The equipment differs in their 
capacity, size, and temperature control systems at different levels. 
Equipment’s are of electricity driven and electric supply is needed to 
maintain the recommended temperature, while others are non-electricity 
driven and it has advantage over the electricity driven is than the temperatue 
can be maintained in absence of electricity supply also. On this basis, it can 
be categorized into electrical and non-electrical equipment’s. (Kartoglu, U. et. 
al 2010) 
3.1. Electrical equipment’s: -
a) Walk-in-Coolers (WIC)
State and Regional/Divisional Stores permit to preserve used Walk-in-Coolers 
s to store the bulk vaccines between +2oC to +8oC. These are used for vaccines, 
like DT, Hepatitis B, TT, DPT, Measles, BCG. Coolers have two identical 
units and generator along with in emergency. These coolers equipped with 
the alarm systems to alarm time to time at the excursions and   temperature 
recorder to record the temperature overall as well. These may get activated 
if the temperature of the cooler exceeds more than+10oC. The coolers are 
equipped at different regional centers and have capacity to store vaccines 25% 
surplus for approximately 4-5 districts and stock for the districts they cater.
b) Walk-in-Freezers (WIF)
Whenever the bulk of oral polio vaccine (OPV) required to be stored then 
these freezers are on the priority. It also has additional advantage of preparing 







a temperature around (-) 20 oC or below. These freezers are available in 
dimension of 16.5 x 32 m3. These freezers are having the additional power 
back-up facility  with standby two alike cooling units.
c) Deep Freezer
Deep Freezers are distributed with top opening lids under national immunization 
program to maintain the integrity of the biologicals. It may control the 
temperature between -15 to -25oC and generally used to store the OPV and 
used to prepare the freezing ice packs. It also has a great advantage to cover the 
temperature range of -15oC to -25oC for 18 & 26 hours at ambient temperatures 
in case of power failure if not opened. The Deep Freezer is having special 
insulation, to control the inside temperature from (-) 25oC to (-) 15oC. About 
4-5 deep freezers have been provided to all districts whereas the small deep 
freezer kept at the PHCs. 
d) Ice Lined Refrigerator (ILR)
The efficiency of the Ice Lined Refrigerators is more and cold air holding capacity 
is more than a normal freezing units having an opening at front. It is capable to keep 
vaccine in safe mode for 24 hour with a very little energy consumption of 8 hours. 
Smaller ILR to PHC headquarters are equipped with the larger ILR while the district 
headquarters should have equipped with bigger ILRs. The manufacturing of the ILRs 
is very simple and walls are composed of lining of water containers (ice packs or 
tubes) and held by the frame.  These refrigerators are very much safe for the vaccines 
due to its property to maintain the inside temperature of the refrigerator at a safer level, 
if the electricity supply fails.
e) Solar Refrigerators
Solar refrigerators work on the principle of normal compression refrigerators 
but a photovoltaic refrigerator has the greater levels of insulation which 
surrounds the compartments of storage to maximize its energy efficiency.
f) Domestic Refrigerators
These are useful to maintain the cabinet temperature between 2 to 8oC as 
needed. It is good to load the refrigerators correctly to preserve the optimum 
temperature for vaccines and diluents. Universal Immunization Program (UIP) 
always prefers the refrigerators (in the rural places where the availability of 





These are big in size and insulated boxes available in different sizes- five, 
eight, twenty and twenty-two with number of ice packs. The ice packs are 
conditioned before the vaccine are placed and should be placed at covering 
the vaccines from all direction with the top lid. The Vaccines are to be 
covered and kept with a layer of pre-conditioned ice packs in vicinity of cold 
boxes. The vaccine vials of DT, TT, DPT, and Hep B shouldn’t be in direct 
contact with the ice packs but when other vaccines like OPV/ BCG/Measles 
are also shipping then DT, TT, DPT, and Hep B should be surrounded by 
OPV/ BCG/Measles vaccines. The pre-conditioning of the ice-packs is 
mandatory and after 20-30 minutes of preconditioning, the vaccines are 
packed accordingly. 
b) Vaccine Carriers
The small quantity carriers called vaccine carriers and these may be used to 
transport the 16-20 vials of vaccines to the sub-regional center. These carriers 
are composed of insulated material which is the main basis of determining the 
life of cold efficiency of the carrier. Maximum four ice packs are to be kept 
in the vaccine carrier as per label specified. Always pre-conditioned ice-packs 
are used and the lid of the carrier should be ensured that it has been closed 
tightly or not to prevent any kind of loss of energy during the transit. The 
vaccines like  DPT, Hep B, DT, and TT are mandatory to keep in direct contact 
with the ice packs.
c) Ice Packs and their use
In cold chain, ice packs play its role significantly and used for ice lining in 
between the cold boxes. The deep freezer may generate the ice packs under 
the temperature range of (-) 15 to (-) 25oC. Each manufacturer has its own 
specifications of ice packs. There are the manufacturing guidelines which 
should be complied whenever the desired ice pack is to be used for vaccine/
biologicals during the shipment from one place to another.
3.3 Temperature monitoring devices
When the immunological products like vaccines are transported from one 
place to another then it is essential that the temperature change is bound to 
happen during the transition?  The devices are useful to measure the changes 
in temperature thus recording the temperature of the biologicals/vaccines 
during transit and storage with the help of various type of thermometers 
and equipments is advantageous. These instruments record the temperature 
and explore the chart of date of dispatch to date of delivery along with the 
temperature variations. If any temperature excursions are observed and the 







immunization. Thus, the temperature devices are essential to make the NIP 
successful. (Lewis, P.R et. al. 2001) 
3.3.1 Dial Thermometers (DT)
These thermometersare used to measure and record the temperature of the 
products in the Ice Lined Refrigerators (ILRs). A moving needle is there in the 
device to determine and gives the indication about the temperature of vaccine/
biologicals in the stipulated temperature range of -50oC to +50oC. (Lewis, P.R 
et. al. 2001) 
3.3.2 Data Logger or Electronic Data Logger (EDL)
These data loggers play a significant role to record and store the data related to 
all temperature deviations (if any) during the transit of the boxes/ILR in which 
vaccines are stored. This electronic device is kept with the vaccine and it can 
record the vaccine temperature for 30 days or more as per design. An alarm 
system is built inside the logger and the safe range alarm alerts the handlers as 
soon as the temperature excursions occurs out of the stipulated ranges. (Lewis, 
P.R et. al. 2001) 
3.3.3 Alcohol Stem Thermometers (AST)
The sensitivity of these kind of thermometers are quite high and with the 
reason they produce more precise, more reproducible and accurate results than 
dial thermometers. One advantage with the thermometer is that it may be used 
for deep freezers and ILRs also from -50oC to +50oC. (Lewis, P.R et. al. 2001) 
This device is helpful to monitor the vaccines exposed to less than 0oC. 
This is composed of the electronic temperature measuring circuit with LCD 
display. Its alarm becomes on if the temperature goes below -0.5oC (for more 
than 60 minutes) and “good” status to “alarm” status will be displayed on the 
screen during the excusions of temperature. There is a specially provision that 
and it must be kept between freeze sensitive vaccines (Hepatitis B, DPT, TT, 
DT etc.). Here is a cross on it and once it changes the cross, it cannot be further 
re-used and will be eliminated, means it is only one time use and no one can 
change the readings also. (Lewis, P.R et. al. 2001) 
4. METHODOLOGY OF VACCINE VIALS EVALUATION
The expiry dates of the products are the key factors to assess the utilization and 
no-utilization. Thus it plays a crucial role in the quality control and inventory 
control of the products (biologicals/vaccines/food products/drugs etc). The 
expiry date of vaccine as depicted in figure 4 are the guidelines indicated on 
the vials about to use or not to be used.
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There are different ways to depict the expiry dates but two procedures are 
adopted and there are 1. Year along with the month of expiry 2. Year with date 
and month of the expiry. When the date, month and year has mentioned as the 
expiry then the product should not be further used after that date, month in the 
year while if only month  with the year mentioned in that case vaccines might 
be used till the last date of the month in that year as explained in the figure 4. 
(Kartoglu, U., et. al. 2010 ad Murhekar, et al. 2013)
Vaccines should be used on or before the expiration date—it is the date 
known as “beyond use date” (BUD). The basis of the calculation of BUD is 
depends on its opening and the person who opens first; entered the date of opening 
and its use beyond the date mentioned by him. Thus now the expiry date of the 
vaccine is replaced by this new date and it is the BUD for this opened vial or it 
may be used before the expiry date of the product.  This new BUD information 
given by the person on the label of the vaccine vial should be initialed who made 
the change. (Stamatis D.H. 2003 and Kartoglu, U. et al. 2012) 
Reconstituted vaccines have a limited period for their use and once the 
reconstitution of the vaccine done and diluent admixed with vaccine then the 
BUD should be mentioned. This period or BUD is labeled on the vial or on 
package insert so another person should aware to use or not to be used with 
the stipulated period. For example, if the label or package inserts of vaccine 
vials indicates to use the vaccine within 30 minutes, it must be used within the 
stipulated time otherwise vaccine must be discarded if not used by that time. 
This period of the vaccine utilization might only apply if the reconstituted 
vaccine is still present in the vial—not after it is drawn into a syringe—so 
check the package insert carefully.







Multidose vials are also having a specified period for use once vials have been entered 
with a needle. For example, the package says that the vaccine must be used within 28 
days and discarded 28 days after it is entered. If the vial is entered on 06/Jan/2017, 
the BUD is 03/Feb/2017.The vaccine should not be used after 3 Feb and because it is 
BUD for the vaccine.
4. REGULATION GUIDELINES OF COLD CHAIN OR SUPPLY 
CHAIN
The regulatory bodies of the different areas like health, food, commerce, railway, 
water, law and many more plays a significant role for planning, designing, 
recording, collecting, reporting and execution of the guidelines under the 
purview or control of these agencies. Similarly, the regulatory of health system 
in every country across the globe has its own regulations to protect the right, 
safety, and wellbeing of human. As for as the immunization is concerned, it is 
an imperative need for the safety of the children and mothers specially when 
they deliver the babies to protect from the undesired diseases which may affect 
the health of the new born in future. Now question is that how the regulatory 
controls the health the public by providing the immunization or vaccination 
but it is challenge for the government or the stakeholders for the maintenance 
of the vaccine’s integrity in terms of potency or efficacy. Therefore, it’s an 
utmost need of the time to control the condition of the biologicals or vaccines 
during the phase of storage, handling and transportation. (Kurzatkowski W et 
al. and  2013 and Burton A,  et al. 2009) 
Thus Public and industry members strengthened the guidelines and 
requirements to meet the potency and quality of the product while distributing, 
storing and handling of temperature-sensitive immunological products. 
The spurious quality of immunological products will not be entertained by 
international organizations like WHO, vaccine cold chain have various global 
regulatory agencies and their requirements, Parenteral Drug Association etc. 
(Stamatis D.H. 2003 and Kartoglu, U. et al. 2012) 
To address the issues related to the cold chain for immunological products 
or other biologicals, different regulatory bodies across the world are inclined 
to issue the regulatory oversight documents for guidance. Three type of 
institutions are accountable for the cold chain related compliance under these 
jurisdictions and these are 1. International Air Transport Association (IATA); 
2. the International Conference on Harmonization; 3. National regulatory 
agencies of Member States (Health Canada, USFDA, EMA) issue guidelines 
for temperature control of drug products during storage and transportation. 
The International Conference on Harmonization of Technical Requirements 
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for Registration of Pharmaceuticals for Human Use (ICH) and Food and 
Drug Administration (FDA) developed the key guidance on the supply chain 
management for temperature-controlled pharmaceutical and biotechnical 
products, including: 
• ICH Harmonised Tripartite Guidelines Q6A and Q6B (Test Procedures 
and Acceptance Criteria for New Drugs and New Biotechnology. (http://
www.ich.org/fileadmin/Public_Web_Site/ICH_Products)
• ICH Guidance for Industry Q1A(R2) Stability Testing of New Drug 
Substances and Products  
• FDA 483 observations on cold chain applications with suggested deviation 
offsets
• FDA CFR Title 21 203.32, 203.36, 211.150
The ICH guidelines are accepted by international community (US, Japan, and 
the European Union) and other developing countries also have faith for the 
standardization of pharmaceutical products.  The FDA addresses three key 
regulations about cold chain and these are: (http://www.ich.org/fileadmin/
Public_Web_Site/ICH_Products)
1. 21 CFR 203.32 “Prescription Drug Marketing – Drug sample storage and 
handling requirements.”  It deals with the “Storage and handling conditions” 
and manufacturers, record distribution, and their representatives are bound 
to comply the labeling and compendia requirements.
2. 21 CFR 203.36 “requirement of shipping, houses, co-marketing 
agreements, and mailing services, with the third-party recordkeeping” in 
storing and shipping the drug samples. It must comply with the Prescription 
Drug Marketing Act (PDMA) and amendments with the recommendations 
relating to 21 CFR Parts 203 and 205.
3. 21 CFR 211.150 of Sub Part H: Holding and Distribution - “Distribution 
procedures” explained about the product shipment under appropriate 
conditions and optimum temperatures with requirements in the current 
edition of an official compendium, such as the United States Pharmacopeia/
National Formulary (USP/NF).” 
Recently, various rigorous alterations and amendments to set the standards 
and putting forward the principles in pharmaceutical cold chain management 
were done to the guidelines including the ones from the United States 
Pharmacopeia, Health Canada, and the European Union.  Thus an additional 
and growing requirements, list of documents, recommendations, legislation, 








• Centres for Disease Control and Prevention (CDC) Guidelines for 
Maintaining and Managing the Vaccine Cold Chain 
• The EU Guide to Good Manufacturing Practice, Annex 13 
• The US Code of Federal Regulations ■ US and European Pharmacopoeia
• WHO Guidelines on the international packaging and shipping of vaccines 
• The Guidelines on Good Distribution Practice (GDP) of Medicinal 
Products 
The course of action in controlling the cold chain is revised about Good Storage 
and Distribution Practices for Drug Products, and the brand new for Good 
Distribution Practices – Supply Chain Integrity, Monitoring Devices – Time, 
Temperature and Humidity and United States Pharmacopeia where it also 
announced the significant changes in the regulatory provisions. Pharmaceutical 
industry or other stakeholders should follow or not to follow depends on 
themselves only and there is no such obligation by law or act for the industry 
to comply these rules/guidelines/procedures strictly, it is the interest of their 
own to do or not to do. The most disadvantages on the guidelines is that only 
they described or explained about “what” must be done; but is has not been 
explained ‘how’ it could be done.  To get the answer of how it could be done, 
WHO published 16 technical supplements on ‘Model guidance for the storage 
and transport of time- and temperature-sensitive pharmaceutical products’ on 
best practices to support the harmonized and it  can be considered a good 
development in this segment. (Afsar A, Kartoglu U. 2006) 
International Air Transport Association (IATA)has a great role and it 
harmonized the new regulation for time- and temperature-sensitive products or 
immunological/biological products for air transport. Still the more exhaustive 
and extensive revisions are needed t to store, handle and the distribute the 
temperature sensitive products under cold supply chain, with more applied, 
more practical, more relevant than previous editions. Vaccine regulations 
for the cold chain is quite complex and multifuctional, which include the 
independent oversight of production, good control of the process and testing 
by a competent regulatory authority.  The compliance of the regulatory and its 
activities initiated at the start of the vaccine development and it is continuous 
process throughout its entire life span. Guidelines developed by the WHO 
presenting the evaluation of the vaccine temperature stability by testing.  The 
key component of the vaccine is the potency and efficiency control along with 
the evaluation pattern of the quality. (Levine, O.S., et al. 2011 and McColloster 
P.J. 2011 ) regulatory ensures that the characteristics of the vaccine quality 
should be tested  before the marketing and loss of potency, as determined/
assessed by a previously validated potency test, which may give the data on 
the loss of vaccine potency. The stability of the immunological products is 
Peepliwal, A
98
serious concern, thus a procedure is required to assess a complete stability 
picture of vaccines. Current models never permit to determine or record the 
unplanned temperature excursions, and thus, the approach is to define limited 
conditions for planned temperature excursions (such as CTC use) and then 
assure a ‘stability reserve’ is requisite of the regulatory. (Levine, O.S., et al. 
2011 and McColloster P.J. 2011 ) 
DISCUSSION
As for as vaccines are concerned, these are required to be stored and supplied 
under the rigorous controlled conditions. It is essential that how the vaccines 
are stored and supplied to the end users with its appropriate integrity along with 
the potency. As for as the prophylactic prevention of diseases are concerned, 
immunization program is quite prominent to curb certain lethal diseases like 
tetanus, polio, diththeria, herpix, cervix cancer, hepatitis (Tembleque M.D.S., 
et.al. 2013) and many more. But the vaccines are manufactured at one place and 
transferred to another under the program. Vaccines are biological constituents 
and might degrade if not controlled under optimum temperature, heat, and 
moisture. These are the key environmental factors affects the potency of the 
vaccines adversely.
Many researchers already emphasized on reduction of vaccine potency 
during the storage and transportation if not controlled. Pediatricians focused 
on casual and unwillingness approach of some medical professionals towards 
the storage and administration of vaccines stating that doctors/nurses keep 
the vials in refrigerator doors which is not having an optimum temperature to 
maintain the biological activity of vaccines. It results into the less/no activity 
or adverse effects of the vaccines occurs. Various equipments like Walk-in-
Freezers (WIF), Ice Lined Refrigerator (ILR), Walk-in-Coolers (WIC),  Deep 
Freezer, Solar Refrigerators, Domestic Refrigerators, Cold Box, Vaccine 
Carriers, Ice Packs are in use to assist the vaccines to maintain the overall 
potency of the vaccines during storage, and transportation. Many monitoring 
devices i.e. Dial Thermometers, Electronic Data Logger, Electronic Data 
Logger, Alcohol Stem Thermometers, Alcohol Stem Thermometers are quite 
efficient to assess the transit temperature and moisture deviations during the 
storage and transportations to avoid any undesired adverse reactions. (Afsar 
A. and Kartoglu U. 2006) Here in this paper author also emphasized on the 
evaluation of vaccine expiry and how it could be calculated as to use and 
not to use if vial is beyond the use date (BUD). The vaccine potency and its 
utilization can be assessed with the color display of the vaccine content in the 
vial stating discard and beyond the discard point at the time of administration 







Apart from that the regulations and guidelines framed time to time by 
the World Health Organization (WHO), ICH, Parenteral Drug Association, 
the International Air Transport Association (IATA) and the International 
Conference on Harmonization; Members state’s National regulatory agencies 
(for example Health Canada, USFDA, EMA) to ensure the adequate biological 
efficacy of the vaccines. These regulatory organizations framing the guidelines 
and plays key role in cold chain management of vaccine to reach the Primary 
health care centers (PHCs) with the desired potency. (Levine, O.S., et al. 2011 
and McColloster P.J. 2011)
Approximately, one-third of refrigerators had temperatures deviations 
or out of the range where the recommended range of 2-8 degrees centigrade 
is essential. The quality of the old refrigerators or coolers might show the 
inappropriate temperatures than newer ones. To protect and avoid the 
deviations during the storage, adequate information, knowledge, skill and 
practice for the handling and storage of vaccines required perfectly at primary 
health care centers or the physicians’ offices. (Yuan, L. et.al. 1995)
Minimization of expiry risk of vaccines should be kept in mind and keep 
efforts to maintain the stock of the vaccine which required to be further used 
for next 1-3 months only. The order of the same kind of the vaccines are 
placed together to avoid any data related confusion during the storage and 
transportation. The expiry dates of the vaccines are evaluated and inspected a 
regularly way. The best method of doing this is that the older vaccines (having 
the expiry very near) should be moved to the front doors of the refrigerators 
and use these lots first.  The date of the first withdrawn from the vaccine vial 
should be marked on the label of the multidose vial.  The open vial of the 
vaccine must be discarded within 30 days (if not specified by the manufacturer 
for discard after the opening or follow the instructions as specified by the 
manufacturer) (Erica W. et. al. 2004)
The objective of the review paper is to address the compliance about the 
cold chain of the immunological products efficiently, logistic management, and 
overall maintenance of the immunological products like vaccines/antibodies 
during the storage, transportation and vial check or assessment at the time 
of administration to the end user child/mother at the Primary Health Care 
centers and it could be maintained across the nation without any deviation 
and negligence to avoid untoward medical occurrence due to vial content 
deterioration.
CONCLUSION AND IMPICATIONS
The cold chain management (CCM) of immunological products is the utmost 
need of hour under Universal Immunization program (UIP) and National 
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Immunization program (NIP). The paper itself described the techniques to 
control the immunological products/ biological products how it could be 
stored, shipped, handled, and administered safely to the end users without 
affecting the potency of vaccines. The equipment’s used in the cold chain 
should be calibrated and having international standards to monitor the overall 
transit temperature of the vaccines to ensure the temperature control under the 
desired conditions. The regulatory guidance from the USA, Japan, European 
Union and ICH has developed the exhaustive document to make the successful 
execution of immunization program. Day to day observations and deleterious 
effect of vaccines due to storage and handling issues are elaborated in the review 
paper which reflects to manage the CCM effectively. Thus, the cold chain 
management prevail the overall process of immunization for implementation 
and achievement of immunization programs successfully across nation and 
worldwide as well.
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